Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors.
4-Hydroxyl pyrazole derivatives
Ferroptosis inhibitor
Radical-trapping antioxidant
Structure-activity relationship
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
05 Jan 2024
05 Jan 2024
Historique:
received:
04
09
2023
revised:
11
10
2023
accepted:
24
10
2023
medline:
4
12
2023
pubmed:
12
11
2023
entrez:
11
11
2023
Statut:
ppublish
Résumé
Ferroptosis, an iron-dependent form of regulated cell death, has been well recognized as a pathogenic mechanism in driving many diseases, such as neurodegenerative disorders, ischemia-reperfusion (I/R) injury. Blocking ferroptosis has been emerging as a feasible therapeutic strategy for the prevention and treatment of these diseases. However, novel potent ferroptosis inhibitors remain to be developed for further clinical applications. In this study, we screened our in-house compound libraries by phenotypic assays and identified a 4-hydroxyl pyrazole derivative HW-3 with good ferroptosis inhibitory activity (EC
Identifiants
pubmed: 37950965
pii: S0223-5234(23)00880-2
doi: 10.1016/j.ejmech.2023.115913
pii:
doi:
Substances chimiques
Antioxidants
0
Iron
E1UOL152H7
Hydroxyl Radical
3352-57-6
Hydrocarbons
0
Pyrazoles
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115913Informations de copyright
Copyright © 2023. Published by Elsevier Masson SAS.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.